Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab
Digital health technology (DHT) tools for Parkinson’s disease (PD) e.g., smartphones and wearables were used for remote and frequent measurement of motor signs in the phase 2 PASADENA study of the anti-alpha-synuclein monoclonal antibody…
Continue Reading